Adagene (ADAG)

• Market cap: $170M
• 1 day: -7.91%
• 5 days: -7.67%
• 1 month: 7.76%
• 3 months: 95.14%
• 6 months: 77.83%
• Year to date: 96.2%
• 1 year: 103.95%
• 5 years: -79.65%
• 10 years: -87.96%
• Sector: Healthcare
• Industry: Biotechnology

About: Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Employees: 138